4//SEC Filing
ALNYLAM PHARMACEUTICALS, INC. 4
Accession 0001325812-15-000067
$ALNYCIK 0001178670operating
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 5:08 PM ET
Size
5.3 KB
Accession
0001325812-15-000067
Insider Transaction Report
Form 4
Gros David-Alexandre C
SVP, Chief Business Officer
Transactions
- Award
Stock Option (right to buy)
2015-12-18+15,012→ 15,012 totalExercise: $88.95Exp: 2025-12-18→ Common Stock (15,012 underlying)
Footnotes (1)
- [F1]The stock option vests as to 25% of the shares on the 1st anniversary of the date of the stock option grant and as to an additional 6.25% of the shares each successive three month period thereafter.
Documents
Issuer
ALNYLAM PHARMACEUTICALS, INC.
CIK 0001178670
Entity typeoperating
Related Parties
1- filerCIK 0001178670
Filing Metadata
- Form type
- 4
- Filed
- Dec 21, 7:00 PM ET
- Accepted
- Dec 22, 5:08 PM ET
- Size
- 5.3 KB